Clinical Trials in Tennessee

Showing 3361-3380 of 20,239 trials

MoVE Trial: Motivational Strategies to Empower African Americans to Improve Dialysis Adherence

NCT05735743

MoVE Trial is a randomized clinical trial designed to rigorously test the impact of a behavioral intervention (culturally tailored motivational interviewing - (MOVE)) delivered by trained health coaches, on hemodialysis treatment non-adherence. It is a a two-arm, parallel group randomized clinical trial with 24-week follow-up. It involves completion of surveys by patients enrolled in the study. It also involves participation in motivational interviewing sessions by patients who are randomized to the intervention (MI).

End Stage Renal Disease on Dialysis

Vanderbilt University Medical Center176 participantsStarted Oct 2023

Philadelphia, Pennsylvania, United States • Philadelphia, Pennsylvania, United States • Philadelphia, PA 19123, Pennsylvania, United States +3 more locations

Enrolling By Invitation29 miles

Abundance and Distribution of Lipids and Proteins in Nonalcoholic Fatty Liver Disease (NAFLD)

NCT00983463

Nonalcoholic fatty liver disease (NAFLD) is the most common type of liver disease in the United States. The incidence of NAFLD is very similar to that of obesity, type 2 diabetes, and the metabolic syndrome. The investigators hypothesize that there may be a relationship between over-nutrition, decreased physical activity and the development of fatty liver. The purpose of this study is to identify the types of fats and proteins, and the quantity of each, that are associated with increased severity of NAFLD.

Nonalcoholic Fatty Liver Disease

Vanderbilt University45 participantsStarted Oct 2009

Nashville, Tennessee, United States

MoVE Trial: Motivational Strategies to Empower African Americans to Improve Dialysis Adherence

Abundance and Distribution of Lipids and Proteins in Nonalcoholic Fatty Liver Disease (NAFLD)

Find Trials by Condition in Tennessee

Study of Cabozantinib in Combination With Atezolizumab Versus Second NHT in Subjects With mCRPC

Diabetes Medical Nutrition Therapy in Southeastern African American Women

NATIENS: Optimal Management and Mechanisms of SJS/TEN

A Study in Participants With Obesity or Overweight With at Least One Weight-related Comorbidity

An Extension Study for Treatment of Moderately to Severely Active Ulcerative Colitis

Study to Evaluate CCS1477 (Inobrodib) in Haematological Malignancies

STEP TEENS Weight Maintenance: A Research Study on How Well Semaglutide Helps Teenagers With Excess Body Weight to Lose Weight and Maintain Weight Loss

A Phase 1/2 Study of AURN001 in Subjects With Corneal Edema Secondary to Corneal Endothelial Dysfunction (ABA-1)

A Study of Androgen Annihilation in High-Risk Biochemically Relapsed Prostate Cancer

A Phase 3 Study of F14 for Management of Pain Following Total Knee Replacement

A Study of JNJ-64619178, an Inhibitor of PRMT5 in Participants With Advanced Solid Tumors, NHL, and Lower Risk MDS

Axitinib With or Without Anti-OX40 Antibody PF-04518600 in Treating Patients With Metastatic Kidney Cancer

Omnipod® SmartAdjust 2.0 System Compared to the Omnipod® 5 System in Individuals With Type 1 or Type 2 Diabetes

Pulmonary Artery DenerVation Clinical Study Using the Gradient Denervation System in Heart Failure Patients With Pulmonary Hypertension Group 2 (PreVail-PH2 Study)

A Study of Efficacy, Safety, and Tolerability of KAN-101 in People With Celiac Disease

Addressing Risk Through Community Treatment for Infectious Disease and Opioid Use Disorder Now (ACTION) Among Justice-involved Populations

An Observational LTFU Study for Patients Previously Treated With Autologous ex Vivo Gene Therapy for ADA-SCID

Long-Term Follow-Up (LTFU) for Gene Therapy of Leukocyte Adhesion Deficiency-I (LAD-I)